JGC
ADAP

J. Goldman & Co’s Adaptimmune Therapeutics ADAP Stock Holding History

J. Goldman & Co’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-311,153
Closed -$3.12M – 214
2020
Q2 		$3.12M Buy
+311,153
New +$3.12M 0.19% 96